Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...
Dealbreaker on MSN16h
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees to Acquisition by Private EquityCarlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million.
Hosted on MSN18h
JP Morgan Upgrades bluebird bio (BLUE)Fintel reports that on February 24, 2025, JP Morgan upgraded their outlook for bluebird bio (NasdaqGS:BLUE) from Underweight ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.
EnPlusOne uses what it calls a “universal enzyme,” one enzyme that can make multiple modifications, which Ahlstedt says is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback